These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 12819932)
1. Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer. Iwase H; Zhang Z; Omoto Y; Sugiura H; Yamashita H; Toyama T; Iwata H; Kobayashi S Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S34-8. PubMed ID: 12819932 [TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma. Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078 [TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer? Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124 [TBL] [Abstract][Full Text] [Related]
4. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
5. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters. Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients. Altundag O; Altundag K; Gunduz M Med Hypotheses; 2004; 63(4):684-7. PubMed ID: 15325017 [TBL] [Abstract][Full Text] [Related]
7. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393 [TBL] [Abstract][Full Text] [Related]
8. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex. Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412 [TBL] [Abstract][Full Text] [Related]
9. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors. Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616 [TBL] [Abstract][Full Text] [Related]
10. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation. Power KA; Thompson LU Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916 [TBL] [Abstract][Full Text] [Related]
11. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Ariazi EA; Clark GM; Mertz JE Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245 [TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414 [TBL] [Abstract][Full Text] [Related]
13. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor. Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729 [TBL] [Abstract][Full Text] [Related]
14. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer. Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of estrogen receptor beta in breast cancer. Saji S; Hirose M; Toi M Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():21-6. PubMed ID: 16273360 [TBL] [Abstract][Full Text] [Related]
16. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of oestrogen receptor beta in breast cancer. Speirs V; Kerin MJ Br J Surg; 2000 Apr; 87(4):405-9. PubMed ID: 10759732 [TBL] [Abstract][Full Text] [Related]
18. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development. Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154 [TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer. Sugiura H; Toyama T; Hara Y; Zhang Z; Kobayashi S; Fujii Y; Iwase H; Yamashita H Jpn J Clin Oncol; 2007 Nov; 37(11):820-8. PubMed ID: 17932113 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer. Bostner J; Skoog L; Fornander T; Nordenskjöld B; Stål O Clin Cancer Res; 2010 Mar; 16(5):1624-33. PubMed ID: 20179234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]